| Financial Year |
March 31 2023 |
| Monetary Funds |
53,319,914.48 |
| Held-for-trading Financial Assets |
45,000,000.00 |
| Notes Receivable |
575,000.00 |
| Accounts Receivable |
121,120,794.07 |
| Advances to Suppliers |
55,684,981.17 |
| Other Receivables |
26,696,806.21 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
81,752,579.65 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,997,380.04 |
| Total Current Assets |
416,147,455.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
453,317,551.37 |
| Under-construction Projects |
165,883,593.89 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
89,395,575.94 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
42,712,131.96 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
14,869,251.67 |
| Deferred Income Tax Assets |
14,234,014.28 |
| Other Non-Current Assets |
99,384,979.62 |
| Sub-Total of Non-Current Assets |
997,769,873.81 |
| Total Assets |
1,413,917,329.43 |
| Short-Term Loans |
19,500,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
14,796,153.90 |
| Accounts Payable |
357,551,679.58 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,101,182.15 |
| Taxes Payable |
19,325,033.25 |
| Interest Payable |
-- |
| Dividend Payable |
230,235.51 |
| Other payables |
95,996,438.92 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
22,332,480.71 |
| Other Current Liabilities |
35,386,529.61 |
| Sub-Total of Current Liabilities |
726,154,034.09 |
| Long-term Loans |
104,710,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
6,887,885.27 |
| Deferred Income Tax Liabilities |
2,941,520.88 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
142,964,665.64 |
| Total Liabilities |
869,118,699.73 |
| Paid-In Capital(Or Share Stock) |
174,139,457.00 |
| Capital Surplus |
607,588,994.92 |
| Surplus Reserve |
32,507,419.10 |
| LESS:Treasury Stock |
21,315,318.68 |
| Undistributed Profits |
-234,899,195.30 |
| Minority Stockholder's Interest |
-3,222,727.34 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
548,021,357.04 |
| Owner's Equity（Stockholder's Equity） |
544,798,629.70 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,413,917,329.43 |
